Longeveron (LGVN) EPS (Basic) (2020 - 2026)

Longeveron's (LGVN) quarterly EPS (Basic) came in at -$0.0 in Q1 2026, up 48.51% year-on-year from -$0.0 in Q1 2025, and up 27.77% quarter-over-quarter from -$0.0 in Q4 2025.

Longeveron (LGVN) EPS (Basic) (2020 - 2026) Analysis & Trends

Longeveron's EPS (Basic) history runs 7 years deep, the most recent figure standing at -$0.0 for Q1 2026.

  • On a quarterly basis, EPS (Basic) rose 48.51% year-over-year to -$0.0 in Q1 2026; TTM through Mar 2026 was -$0.0, a 48.2% increase from a year earlier, with the FY2025 full-year figure at -$0.0, up 50.63% from the prior year.
  • EPS (Basic) climbed to -$0.0 in Q1 2026 per LGVN's latest filing, from -$0.0 in the prior quarter.
  • Across five years, EPS (Basic) topped out at -$0.0 in Q1 2026 and bottomed at -$20.31 in Q1 2023.
  • The 5-year median for EPS (Basic) is -$1.83 (2024), against an average of -$2.41.
  • Across the five-year window, EPS (Basic) tumbled 17507.56% in 2022 and soared 99.99% in 2024, its largest moves.
  • Year by year, EPS (Basic) stood at -$2.13 in 2022, then tumbled by 30.48% to -$2.77 in 2023, then jumped by 99.98% to -$0.0 in 2024, then rose by 28.57% to -$0.0 in 2025, then rose by 27.77% to -$0.0 in 2026.
  • Per Business Quant, the three latest LGVN EPS (Basic) figures stand at -$0.0 (Q1 2026), -$0.0 (Q4 2025), and -$0.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 0.00
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 0.16
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 4.06
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 6.99
7 Belite Bio 62.72 Bn 62.72 Bn - 0.00
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 7.59
9 Revolution Medicines 37.35 Bn 37.35 Bn - -2.29
10 Longeveron 15.18 Bn 15.16 Bn 264,000.00 0.00

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 -1.83
Mar 31, 2024 -1.72
Dec 31, 2023 -2.77
Sep 30, 2023 -2.79
Jun 30, 2023 -2.67
Mar 31, 2023 -20.31
Dec 31, 2022 -2.13
Sep 30, 2022 -2.50
Jun 30, 2022 -2.35
Mar 31, 2022 -1.96
Dec 31, 2021 23.74
Sep 30, 2021 -11.98
Jun 30, 2021 -10.56